Oliveda International, Inc. (OLVI) Announces Shipments of Oliveda Products Worth $10,000 to OLVI Shareholders
18 juil. 2019 11h35 HE
|
OLIVEDA International, Inc.
SANTA MONICA, CA, July 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health...
Relevium Provides Corporate Update on Its Medical Cannabis Strategy
03 juin 2019 11h31 HE
|
Relevium Technologies Inc
MONTREAL, June 03, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on...
Relevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and Vision
24 mai 2019 09h29 HE
|
Relevium Technologies Inc
MONTREAL, May 24, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its OTC business...
Relevium Launches the Push and Pull System™, Targeting a New Revenue Stream in the Burgeoning Cosmeceutical Market
07 févr. 2019 08h31 HE
|
Relevium Technologies Inc
MONTREAL, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the new launch of the...
AngioSoma Committed to Expanding Cosmeceutical Future
08 nov. 2018 09h50 HE
|
AngioSoma, Inc.
New Industry Data and Product Roadmap Align for Optimistic Outlook HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research and...
AngioSoma, Inc. Announces Grant of Patent for Flagship Drug
14 mai 2018 12h13 HE
|
AngioSoma, Inc.
HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to announce that the U.S. Patent Office has agreed to grant our patent application for our flagship...
Entia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide Licensing Agreement for its GROH Beauty Products Line
24 févr. 2017 16h01 HE
|
Entia Biosciences, Inc.
PORTLAND, Ore., Feb. 24, 2017 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) announced that it has licensed to GROH BEAUTY CORP of Deerfield Beach, Florida, the exclusive worldwide rights...
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Convoy Therapeutics, Inc.
19 juin 2013 08h30 HE
|
Crystal Research Associates, LLC
NEW YORK, NY--(Marketwired - Jun 19, 2013) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Convoy Therapeutics, Inc. The...
Oxis International Inc Receives GRAS Status for its Patented L-Ergothioneine Anti-Oxidant
10 oct. 2011 08h30 HE
|
OXIS International Inc.
Beverly Hills, California, Oct. 10, 2011 (GLOBE NEWSWIRE) -- Oxis International Inc. (OTC/Bulletin Board: OXIS.OB and Euronext: OXI.PA) today announced that an independent scientific panel of experts...
Sirona Biochem Identifies Depigmenting Cosmetic Agent for Cosmeceuticals Portfolio
29 juil. 2011 08h00 HE
|
Sirona Biochem Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 29, 2011) - Sirona Biochem Corp. (TSX VENTURE:SBM) (the "Company"), a biotechnology company specializing in carbohydrate chemistry...